Early in his career, the senior author (RCH) became interested in the experimental study of cerebral vasospasm, which continues to be one of the most important causes of morbidity from subarachnoid hemorrhage (SAH).21–23,45 The initial approach was to find a single pharmacological agent, the so-called “silver bullet,” to prevent and reverse vasospasm. Arterial smooth muscle relaxants were the f...